Factors affecting inadequate response to HBV vaccine in hemodialysis patients: northeast anatolia survey with six hemodialysis centers
Yazarlar (12)
Prof. Dr. Halil İbrahim ERDOĞDU Kafkas Üniversitesi, Türkiye
Eray Atalay Kafkas Üniversitesi, Türkiye
Gül Gürsoy Kafkas Üniversitesi, Türkiye
Başol Canbakan Kafkas Üniversitesi, Türkiye
Serkan Aktürk Kars Harakani State Hospital, Türkiye
Canan Yazıcı Ardahan State Hospital, Türkiye
Orhan Yücel Kars Harakani State Hospital, Türkiye
Sinan Mersin Kartal Lutfi Kirdar Education And Research Hospital, Türkiye
Sengül Üçer
Kafkas Üniversitesi, Türkiye
Özgür Merhametsiz Igdir State Hospital, Türkiye
Can Öner Kartal Lutfi Kirdar Education And Research Hospital, Türkiye
Merve Erat
Kafkas Üniversitesi, Türkiye
Devamını Göster...
Makale Türü Açık Erişim Özgün Makale (SSCI, AHCI, SCI, SCI-Exp dergilerinde yayınlanan tam makale)
Dergi Adı Clinical and Experimental Nephrology (Q2)
Dergi ISSN 1342-1751 Dergi Bilgileri (2019)
Dergi Tarandığı Indeksler SCI-Expanded
Makale Dili İngilizce Basım Tarihi 04-2019
Kabul Tarihi 16-11-2018 Yayınlanma Tarihi 28-11-2018
Cilt / Sayı / Sayfa 23 / 4 / 530–536 DOI 10.1007/s10157-018-1676-x
Makale Linki http://link.springer.com/10.1007/s10157-018-1676-x
UAK Araştırma Alanları
İç Hastalıkları
Özet
Background: In hemodialysis patients Hepatitis B virus (HBV) infection is one of the problems. Because of HBV vaccine response is lower than in the general population, in this study it is aimed to determine the factors that may cause inadequate HBV vaccine response in hemodialysis patients. Methods: In study, HBsAg, anti-HBs, anti-HBc IgG data belonging to 278 patients were obtained from file and computer records. It was seen that seronegative cases had been given recombinant HBV vaccine. Anti-HBs titers were monitored 1 month after vaccination was completed. According to this, the patients are divided into two groups. Those with anti-HBs < 10 IU/mL were identified as non-responders and with anti-HBs ≥ 10 IU/mL as responders. Factors such as age, serum albumin and urea reduction rate which may affect inadequate response to HBV vaccine were evaluated. As statistical examination, Chi-square test was used for the analysis of the data determined by counting, and logistic regression was used for statistically significant independent variables in chi-square test. p value of < 0.05 was considered statistically significant (Confidence interval: 95%). Results: Out of 278 patients, according to exclusion criteria 81 patients were excluded. 13.2%(26/197) of HBV vaccinated patients had insufficient response. The inadequate response rate to HBV vaccination was found to be higher in patients with age ≥ 65 (p = 0.039), serum albumin < 3.5 g/dL (p = 0.024) and urea reduction rate ≤ 65 (p = 0.028). No statistically significant relationship was found between inadequate response to HBV vaccine and anti-HCV positivity, presence of diabetes mellitus, anemia status, vitamin D therapy and vascular access pathway variability. Conclusion: We conclude that relatively high patient age, low albumin level and insufficient urea reduction rate may cause inadequate HBV vaccine response. Taking these factors into consideration may provide a useful insight for an adequate response to vaccination.
Anahtar Kelimeler
Hemodialysis | Hemodialysis adequacy | Hepatitis B vaccines | Humoral immune response